Your browser doesn't support javascript.
loading
NABP2 as an oncogenic biomarker promotes hepatocellular carcinoma progression and metastasis.
Peng, Hong; Cai, Shenglan; Chen, Ruochan; Tan, Linxia; Lu, Shanshan; Lu, Xingjun; Hang, Yuanxin; Zhang, Yiya; Peng, Xiaozhen.
Affiliation
  • Peng H; Medical School, Huanghe Science & Technology College Zhengzhou, Henan, China.
  • Cai S; Infection Control Department, Hunan Provincial Maternal and Child Health Care Hospital Changsha, Hunan, China.
  • Chen R; Hunan Key Laboratory of Viral Hepatitis, Xiangya Hospital, Central South University Changsha, Hunan, China.
  • Tan L; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University Changsha, Hunan, China.
  • Lu S; Hunan Key Laboratory of Viral Hepatitis, Xiangya Hospital, Central South University Changsha, Hunan, China.
  • Lu X; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University Changsha, Hunan, China.
  • Hang Y; Hunan Key Laboratory of Viral Hepatitis, Xiangya Hospital, Central South University Changsha, Hunan, China.
  • Zhang Y; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University Changsha, Hunan, China.
  • Peng X; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University Changsha, Hunan, China.
Am J Transl Res ; 15(6): 4203-4227, 2023.
Article in En | MEDLINE | ID: mdl-37434816

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Am J Transl Res Year: 2023 Document type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Am J Transl Res Year: 2023 Document type: Article Affiliation country: China